Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Irinotecan for malignant mesothelioma A phase II trial by the Cancer and Leukemia Group B.

Kindler HL, Herndon JE, Zhang C, Green MR. Irinotecan for malignant mesothelioma A phase II trial by the Cancer and Leukemia Group B. Lung Cancer. 2005 Jun; 48(3):423-8.

View in: PubMed

collapse authors with profiles